SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -3,963.48%.
Criteria proven by this page:
- VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E 0.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -3,963.48%).
- Trailing Earnings Yield -3,963.48% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
Overall SharesGrow Score: 47/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BYAH
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.15
P/S Ratio0.28
EV/EBITDA0.1
Per Share Data
EPS (TTM)$-40.95
Book Value / Share$6.71
Revenue / Share$4.24
FCF / Share$0.00
Yields & Fair Value
Earnings Yield-3,963.48%
Dividend Yield0.00%
SharesGrow IV$4.75 (+316.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2021 |
-25.9 |
0.00 |
-21.71 |
13.48 |
- |
| 2022 |
65.6 |
-0.47 |
83.51 |
6.54 |
- |
| 2023 |
14.7 |
0.04 |
12.40 |
5.10 |
- |
| 2024 |
26.2 |
-0.60 |
8.33 |
5.27 |
- |
| 2025 |
-0.5 |
0.00 |
2.76 |
4.37 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2021 |
$-0.93 |
$931.04K |
$-484.96K |
-52.1% |
| 2022 |
$0.37 |
$1.92M |
$191.3K |
10% |
| 2023 |
$1.63 |
$2.46M |
$852.04K |
34.6% |
| 2024 |
$0.92 |
$2.38M |
$478.56K |
20.1% |
| 2025 |
$-41.38 |
$2.52M |
$-24.36M |
-965% |
